Delivery Order SPE2DB20D3111-SPE2DB24FA5YD

Award Date 12/14/23
Potential Completion Date 12/15/23
Potential Value $7.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB22D3301|SPE2DB25FX6JP, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The award is for the delivery of Lidocaine 5% Patch 30s, a pharmaceutical product, with an ultimate completion date of December 3, 2024 and a ceiling value of $3,884.66. The contract is a Delivery Order under a Firm Fixed Price pricing type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
This federal contract award, valued at $1,805.09, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Lidocaine 5% Patch 30s, a pharmaceutical product, with a performance period through July 2, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that supports federal government agencies, particularly the military and veterans' healthcare systems, through its...
This federal contract award, with the identification number SPE2DB20D1004|SPE2DB24FF6F2, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Lidocaine 5% Patch 30S, a pharmaceutical product, with a ceiling value of $1,586.91 and a completion date of March 18, 2024. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., is a major pharmaceutical distributor and healthcare solutions...
This federal contract award, with ID SPE2DB20D3103|SPE2DB24FM1W3, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lidocaine 5% Patches, a pharmaceutical product, and has a ceiling value of $2,087.58. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of January 9, 2024. It is not designated as a...
This federal contract award, with an ID of SPE2DB22D1106|SPE2DB24FETJ2, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4564689906 - Lidocaine 5% Patch 30s, a pharmaceutical product, with a ceiling value of $8,082.49 and a completion date of May 23, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
This federal contract award, with the ID SPE2DB22D1106|SPE2DB25FDUV1, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Lidocaine 5% Patch 30s, a pharmaceutical product. The award has a ceiling value of $26,265.05 and a performance period ending on January 17, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying...
This federal contract award to Amerisourcebergen Drug Corp is for the delivery of Lidocaine 5% Patch 30s, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $16,819.43 and a period of performance through August 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This federal contract award, with ID SPE2DB22D3301|SPE2DB25FX9GC, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Lidocaine 5% Patch 30s, a pharmaceutical product. The total ceiling value of the contract is $2,363.52, with a firm fixed price pricing type. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and...
This federal contract award, valued at $3,022.77, was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp. The contract is for the delivery of 4567037780 - Lidocaine 5% Patch 30s, a pharmaceutical product. The contract has an ultimate completion date of January 27, 2025 and is structured as a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of Lidocaine 5% Patch 30s. The contract has a ceiling value of $1,842.30 and a completion date of May 21, 2024. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation indicated. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare...
  • SPE2DB20D3111
    Indefinite Delivery Contract
  • SPE2DB20D3111-SPE2DB24FA5YD
    Delivery Order

This federal contract award, with ID SPE2DB20D3111|SPE2DB24FA5YD, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Lidocaine 5% Patch 30s, a pharmaceutical product, with a ceiling value of $7,079.98 and a completion date of December 15, 2023.

Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific contract award is not designated with a set-aside requirement, indicating open competition.

Generated 5/13/25, 10:02 AM